This means that they will usually have a shorter life expectancy than someone with a label of GOLD grade 1, group A. Learn more about the stages of COPD. BODE provides an overall picture of how ...

The SLS is an open label study, and allows a broad range of patients to enrol, creating a more accurate picture of how medicines are used by patients with chronic obstructive pulmonary disease ...

GSK has been studying Nucala in COPD for some time ... and in the interim has had its label extended to include chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...